There were concerns early in the COVID-19 pandemic that immunity to the disease caused by the SARS-CoV-2 coronavirus would be fleeting, due to the rapid decline in antibody levels documented in the months following the recovery of CODID-19 survivors. A new study out of Rockefeller University has confirmed that SARS-CoV-2
Pharmaceutical company AstraZeneca has announced that a manufacturing error has caused what may be a fortunate discovery in regards to the COVID-19 vaccine they are producing, in that the drug may be much more effective at lower doses than anticipated. The Oxford University-developed inoculant is amongst a host of vaccine candidates that
On September 22, 2020, the United States marked a grim milestone in the ongoing COVID-19 pandemic, with the coronavirus having killed its 200,000th victim. The number of American casualties currently stands at 203,800, the highest of any single nation in the world, with the U.S. suffering over one-fifth of the
Health officials in both Russia and around the world are raising concerns over Moscow’s approval of a vaccine to be used against the SARS-CoV-2 coronavirus, despite not having finished critical Phase 3 clinical trials for the new treatment necessary to determine both the effectiveness and safety of the new inoculation.